Dietary Wild Blueberries and Joint Health

NCT06828159 — Not applicable, Recruiting, 50 participants, University of Nevada, Las Vegas

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Effects of Dietary Wild Blueberries on Gut Health and Inflammation and Joint Pain

RegistryNCT06828159
StatusRecruiting
PhaseNot applicable
Study typeInterventional; randomized, crossover, masking: double, other
Enrollment50 (Estimated)
SponsorUniversity of Nevada, Las Vegas (Other); collaborators: Oklahoma Medical Research Foundation
ConditionsGut -Microbiota, Inflammation Biomarkers, Pain Assessment, Joint Pain
InterventionsWild blueberry, Placebo (Dietary supplement)
Datesstart 2025-09-01, primary completion 2027-12-01 (estimated), completion 2028-03-01 (estimated), first posted 2025-02-14, last updated 2025-11-05
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
All trials for Gut -Microbiota All trials for Inflammation Biomarkers All trials of Wild blueberry All trials of Placebo

-Summary

The goal of this proposed study is to examine the effects of dietary wild blueberries on gut microbiome, serum markers of inflammation, and joint function in adults. Each participant will consume 25g freeze-dried blueberries or matched placebo powder for 12 weeks, with a 2-week washout phase between.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Wild blueberriesExperimentalDietary Supplement: Wild blueberry25g freeze-dried wild blueberries daily for 12 weeks
PlaceboPlacebo comparatorDietary Supplement: PlaceboPlacebo powder free from polyphenols matched for calories
  • Wild blueberry (Dietary supplement): Freeze-dried wild blueberry powder 25g/day
  • Placebo (Dietary supplement): Placebo powder matched for calories and no polyphenols

+Outcome measures

Primary outcomes

  • Serum biomarkers of joint function [12 weeks]: Serum biomarkers of inflammation and cartilage degradation will be measured in the wild blueberry and placebo groups and compared for outcomes. Pain scores will also be measured using self-reported questionnaires.

Secondary outcomes

  • Gut microbiome [12 weeks]

+Eligibility

Sex: All, ages: 40 Years to 75 Years

Inclusion Criteria:

* Adults with documented multi-joint/knee arthritis

Exclusion Criteria:

* inability to give informed consent
* pregnancy or lactation
* planned knee replacement surgery
* allergy or contraindication to berries
* recent trauma of the knee responsible of the symptomatic knee
* intra-articular injection in the target knee/hip in the last 3 months
* oral corticosteroid therapy ≥ 5 mg/day (prednisone equivalent) at baseline
* use of berry extracts in the last 3 months
* special diets
* cancer treatment
* bone diseases

+Locations (1)

FacilityCityCountryStatus
OMRFOklahoma City, OklahomaUnited StatesRecruiting